Noven’s Media Center gives you immediate access to current and archived press releases.
Please note that news releases appearing on this website are presented for historical reference, have not been updated for current events, and are current only as of their respective dates of issuance.
- Noven Completes Acquisition of Daytrana® Methylphenidate Transdermal System (Cii) From Shire - (10/01/10)
- Noven To Acquire Daytrana® Methylphenidate Transdermal System From Shire - (08/10/10)
- Noven Appoints Patrick Gallagher As Vice President of Business Development - (02/03/10)
- Noven Announces New Executive Appointments - (01/04/10)